Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hannah E. Henson"'
Autor:
Hannah E. Henson, Michael R. Taylor
Publikováno v:
Cells, Vol 9, Iss 11, p 2340 (2020)
The spliceosome consists of accessory proteins and small nuclear ribonucleoproteins (snRNPs) that remove introns from RNA. As splicing defects are associated with degenerative conditions, a better understanding of spliceosome formation and function i
Externí odkaz:
https://doaj.org/article/df21cdb414a14105bc342c90ea778387
Autor:
Michael R. Taylor, Hannah E. Henson
Publikováno v:
Cells, Vol 9, Iss 2340, p 2340 (2020)
Cells
Volume 9
Issue 11
Cells
Volume 9
Issue 11
The spliceosome consists of accessory proteins and small nuclear ribonucleoproteins (snRNPs) that remove introns from RNA. As splicing defects are associated with degenerative conditions, a better understanding of spliceosome formation and function i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735509b9c16d2bbfff6029af9bbb0a1d
https://doi.org/10.3390/cells9112340
https://doi.org/10.3390/cells9112340
Autor:
Fangzhou Mu, Michael R. Taylor, Jennifer L. Peters, Chaithanyarani Parupalli, Robyn A. Umans, Bensheng Ju, Hannah E. Henson, Jessica Plavicki, Kevin A. Lanham
The blood-brain barrier (BBB) plays a vital role in the central nervous system (CNS). A comprehensive understanding of BBB development has been hampered by difficulties in observing the differentiation of brain endothelial cells (BECs) in real-time.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266ce4653026dff1bbb1b0f48fc15aef
https://europepmc.org/articles/PMC5682946/
https://europepmc.org/articles/PMC5682946/
Autor:
Hannah E. Henson, Bensheng Ju, Wenbiao Chen, Sujuan Jia, Brent A. Orr, Michael R. Taylor, Jan M. Spitsbergen, Christopher J. Eden
Publikováno v:
Molecular Cancer
Background Zebrafish have been used as a vertebrate model to study human cancers such as melanoma, rhabdomyosarcoma, liver cancer, and leukemia as well as for high-throughput screening of small molecules of therapeutic value. However, they are just e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eefeb9e239ccb576590619fd3a6cb8f
https://doi.org/10.1186/s12943-015-0288-2
https://doi.org/10.1186/s12943-015-0288-2
Autor:
Wilda Orisme, Herwig Baier, Sujuan Jia, Chaithanyarani Parupalli, Hannah E. Henson, Bensheng Ju, Michael R. Taylor, Akira Muto
Publikováno v:
Human molecular genetics. 23(11)
Mutations in the human CACNA1F gene cause incomplete congenital stationary night blindness type 2 (CSNB2), a non-progressive, clinically heterogeneous retinal disorder. However, the molecular mechanisms underlying CSNB2 have not been fully explored.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3d38ae3251565457441842ca83d360
https://pubmed.ncbi.nlm.nih.gov/24419318
https://pubmed.ncbi.nlm.nih.gov/24419318
Publikováno v:
Cancer Research. 75:IA19-IA19
The blood-brain barrier (BBB) plays an important role in the treatment of brain tumors. Yet, a comprehensive understanding of brain tumor vasculaturization has been hampered by difficulties in observing this process in vivo. Recently, we have generat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f829a6fc8c2697cc4d6e9afe53af95b9
https://doi.org/10.1158/1538-7445.brain15-ia19
https://doi.org/10.1158/1538-7445.brain15-ia19
Autor:
Wenbiao Chen, Bensheng Ju, Peter Vogel, Sujuan Jia, Chaithanyarani Parupalli, J. Wu, Jennifer L. Peters, Hannah E. Henson, Yong Dong Wang, J. Lu, Brent A. Orr, Michael R. Taylor, Jan M. Spitsbergen
Publikováno v:
Oncogenesis
Dysregulation of Sonic hedgehog (Shh) signaling has been implicated in glioma pathogenesis. Yet, the role of this pathway in gliomagenesis remains controversial because of the lack of relevant animal models. Using the cytokeratin 5 promoter, we ectop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f189c159c27677a46967880cba5397a
https://doi.org/10.1038/oncsis.2014.10
https://doi.org/10.1038/oncsis.2014.10